Ironwood Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	547	685	1,616	1,778	1,678	1,491
Market Cap Growth	68.70%	-57.62%	-9.14%	5.99%	12.55%	-19.85%
Enterprise Value	935	1,193	2,184	1,630	1,586	1,606
Last Close Price	3.66	4.18	10.10	11.53	10.40	9.20
PE Ratio	22.47	805.60	-	10.86	3.61	17.17
PS Ratio	1.89	2.02	4.03	4.63	4.61	4.68
PB Ratio	-2.43	-2.35	-5.16	2.91	3.15	29.11
P/TBV Ratio	-	-	-	2.91	3.15	29.11
P/FCF Ratio	9.48	6.86	9.75	6.95	7.29	10.92
P/OCF Ratio	9.48	6.85	9.74	6.94	7.29	10.80
EV/Sales Ratio	3.25	3.52	5.45	4.24	4.36	5.04
EV/EBITDA Ratio	7.40	12.64	12.23	6.92	7.72	12.23
EV/EBIT Ratio	7.67	12.91	12.33	6.96	7.77	12.41
EV/FCF Ratio	16.22	11.95	13.18	6.37	6.90	11.76
Debt / Equity Ratio	-2.26	-1.99	-2.07	0.64	0.79	7.24
Debt / EBITDA Ratio	4.02	5.89	3.56	1.63	2.01	2.76
Debt / FCF Ratio	8.84	5.80	3.91	1.52	1.82	2.72
Net Debt / Equity Ratio	-1.73	-1.70	-1.80	-0.37	-0.24	1.46
Net Debt / EBITDA Ratio	3.14	5.23	3.16	-0.95	-0.62	0.57
Net Debt / FCF Ratio	6.77	4.94	3.40	-0.88	-0.55	0.55
Asset Turnover	0.86	0.86	0.56	0.37	0.49	0.81
Quick Ratio	1.08	4.39	0.80	30.23	4.54	15.07
Current Ratio	1.13	4.70	0.85	30.58	4.61	15.41
Return on Equity (ROE)	-	-	-674.04%	27.83%	158.09%	-
Return on Assets (ROA)	22.88%	14.56%	15.58%	14.05%	17.21%	20.57%
Return on Invested Capital (ROIC)	22.42%	0.53%	56.83%	39.75%	75.47%	98.13%
Return on Capital Employed (ROCE)	93.60%	30.70%	100.40%	23.30%	24.10%	30.00%
Earnings Yield	4.45%	0.12%	-56.11%	9.21%	27.69%	5.82%
FCF Yield	10.54%	14.59%	10.25%	14.40%	13.71%	9.16%
Buyback Yield / Dilution	-9.90%	-2.99%	16.57%	-13.32%	-2.34%	-2.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.